Based on our results and the low risk associated with L-carnitine supplementation, we suggest oral supplementation with carnitine for GLUT1-DS patients on KD for dietary intervention with a starting dose of 10–50 mg/kg per day [41]. Here, SLC2A1 is linked to Dravet syndrome.